Sawgrass Asset Management LLC Has $6.09 Million Holdings in Danaher Corporation $DHR

Sawgrass Asset Management LLC decreased its holdings in Danaher Corporation (NYSE:DHR) by 52.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,701 shares of the conglomerate’s stock after selling 34,026 shares during the quarter. Sawgrass Asset Management LLC’s holdings in Danaher were worth $6,087,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the 2nd quarter valued at $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth $28,000. Red Tortoise LLC grew its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Finally, Tripletail Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth $31,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the subject of several recent analyst reports. Jefferies Financial Group upped their price objective on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Barclays upped their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. HSBC boosted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, December 1st. Robert W. Baird set a $247.00 price target on Danaher in a research note on Wednesday, October 22nd. Finally, Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Twenty research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $252.09.

Danaher Price Performance

Shares of DHR opened at $234.91 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a market cap of $165.93 billion, a PE ratio of 48.43, a PEG ratio of 3.58 and a beta of 0.89. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The business has a 50-day simple moving average of $230.26 and a two-hundred day simple moving average of $213.17.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is 26.39%.

Insider Activity

In other news, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 30,248 shares of company stock valued at $6,609,663. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.